Spring Vision, an Israeli company, develops, manufactures and will soon market non-intrusive, real-time multispectral retinal imaging devices based on its proprietary breakthrough technology. Led by CEO Noam Allon, who brings 35 years of executive experience in medical imaging companies, the company focuses on developing ground breaking products that will benefit both physicians and patients, with emphasis on accuracy and fast response, a variety of new capabilities and ease of use.

Spring Vision also develops a self-operated autonomous device, using the company’s IP-protected technology platform, combined with deep learning and AI to diagnose a wide range of diseases non-invasively and in real time.